Oppenheimer Asset Management’s Health Catalyst HCAT Stock Holding History

Oppenheimer Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,464	Closed	-$221K	–	1178
2022 Q1	$221K	Sell	8,464 -94	-1%	-$2.67K	﹤0.01%	1104
2021 Q4	$339K	Sell	8,558 -78	-0.9%	-$3.56K	﹤0.01%	1050
2021 Q3	$432K	Buy	8,636 +104	+1%	+$5.67K	0.01%	971
2021 Q2	$474K	Sell	8,532 -441	-5%	-$23.5K	0.01%	977
2021 Q1	$420K	Sell	8,973 -834	-9%	-$40.4K	0.01%	961
2020 Q4	$427K	Buy	9,807 +155	+2%	+$5.72K	0.01%	904
2020 Q3	$353K	Buy	+9,652	New	+$328K	0.01%	897

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Oppenheimer Asset Management's HCAT Position: Q2 2022 in Review

Oppenheimer Asset Management sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 8,464 shares — an estimated $221K sold.

Oppenheimer Asset Management first reported a position in HCAT in Q3 2020 and held it in 7 quarters. The position peaked at $474K in Q2 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

Oppenheimer Asset Management reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
Oppenheimer Asset Management sold 8,464 Health Catalyst shares in Q2 2022, an estimated $221K.
Oppenheimer Asset Management first reported a position in Health Catalyst in Q3 2020 and held it in 7 quarters.
Oppenheimer Asset Management's Health Catalyst position peaked at $474K in Q2 2021.
179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.